Companies: 10,795·Total market cap: $144.5T
TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc.

RNAZNASDAQHealthcare● Active
$5.09
$-0.51(-9.11%)
Market Cap$4837032
P/E Ratio—
52W High$20.99
52W Low$3.82
SplitsDividends

TransCode Therapeutics, Inc. (RNAZ) Stock Splits

Forward and reverse split history, cumulative multiple, latest ratio, and share calculator on this tab.

FMP · RNAZ · as of Jun 8, 2026

Key split metrics

Total Splits4Since IPO (Jul 8, 2021)
Most Recent SplitMay 15, 2025Reverse · 1-for-28
Cumulative Multiple×0.00001 share (2021) → 0.0000 shares today

Latest Split Event

Reverse Split
May 15, 2025
BEFORE SPLIT$0.3500Closing price · May 14, 2025
1-for-28
AFTER SPLIT$8.25Opening price · May 15, 2025
Every 28 shares were consolidated into 1 share.·Total market cap unchanged.·Source: FMP · Historical EOD

Stock Split History

RNAZ · 4 records
Date↓RatioTypeMultiple↕Cumulative↕
May 15, 20251-for-28Reverse×0.036×0.00e+0
Dec 4, 20241-for-33Reverse×0.030×0.00e+0
Jan 16, 20241-for-40Reverse×0.025×0.001
May 23, 20231-for-20Reverse×0.050×0.050
4 splits since IPO · Jul 8, 2021Data: Financial Modeling Prep · Updated daily

Stock Split Calculator

If you bought 100 shares purchased of RNAZ on Jan 1, 2020 — — how many shares would you hold today after all splits?

ORIGINAL SHARES100
→
SHARES TODAY0.0001
Splits Applied4
Total Multiplier×0.00
Split Period2023–2025
Splits applied:May 23, 2023 · 1-for-20Jan 16, 2024 · 1-for-40Dec 4, 2024 · 1-for-33May 15, 2025 · 1-for-28
Based on purchase date Jan 1, 2020Share count only · excludes price / dividendsSource: FMP

This calculator shows how stock splits affected share count only. It does not reflect current market value, dividend payments, or transaction costs. Past splits do not guarantee future performance.

About reverse stock split history

TransCode Therapeutics, Inc. (RNAZ) has undergone 4 reverse stock splits. The most recent was a 1-for-28 reverse split on May 15, 2025. Reverse splits consolidate shares to increase the per-share price.

Price historyShares outstandingFinancialsEarningsMarket capForecast

Frequently asked questions

TransCode Therapeutics, Inc. (RNAZ) has undergone 4 reverse stock splits. Reverse splits consolidate shares, reducing share count while increasing the per-share price.

RNAZ reverse stock split historyhow many reverse splits for RNAZRNAZ stock split countcumulative split multiple
Data: Financial Modeling Prep · Updated daily · For informational purposes only, not investment advice.